ZIVO Bioscience Goodwill and Intangible Assets 2016-2025 | ZIVO

ZIVO Bioscience goodwill and intangible assets from 2016 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

ZIVO Bioscience Goodwill and Intangible Assets 2016-2025 | ZIVO

ZIVO Bioscience goodwill and intangible assets from 2016 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$245.4B
Amgen (AMGN)$157.5B
Gilead Sciences (GILD)$146.4B
Vertex Pharmaceuticals (VRTX)$100B
Bristol Myers Squibb (BMY)$98.1B
CSL (CSLLY)$85.5B
GSK (GSK)$79.6B
Regeneron Pharmaceuticals (REGN)$60.8B
Alnylam Pharmaceuticals (ALNY)$59.9B
Argenex SE (ARGX)$40.5B
BioNTech SE (BNTX)$27.1B
Insmed (INSM)$26.9B
Royalty Pharma (RPRX)$20.9B
Biogen (BIIB)$19.9B
Incyte (INCY)$16.6B
Illumina (ILMN)$15.5B
Genmab (GNMSF)$15.3B
Genmab (GMAB)$15B
Ascendis Pharma (ASND)$11.9B
BioMarin Pharmaceutical (BMRN)$11B
Moderna (MRNA)$10.9B
QIAGEN (QGEN)$10.8B
Swedish Orphan Biovitrum (BIOVF)$10.3B
Exelixis (EXEL)$10.2B
Verona Pharma American Depositary Share (VRNA)$9B
Exact Sciences (EXAS)$8.5B
Bio-Techne Corp (TECH)$8.4B
Blueprint Medicines (BPMC)$8.3B
Halozyme Therapeutics (HALO)$8.1B
Roivant Sciences (ROIV)$8B